SCPX Scorpius Holdings Inc.

  1. Stocks
  2. Healthcare
  3. NYSEAMERICAN: SCPX

Price (delayed)

$0.18

Market cap

$6.49M

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$1.74

Enterprise value

$20.09M

heat biologics is a clinical-stage company focused on developing its proprietary impact™ (immune pan-antigen cytotoxic therapy), a fully allogeneic (“off-the-shelf”) cell-based immunotherapy for use in the treatment of a wide ...

Highlights
The gross margin has soared by 124% from the previous quarter but it has contracted by 22% YoY
The quick ratio has plunged by 87% YoY but it has grown by 7% from the previous quarter
Scorpius Holdings's equity has shrunk by 58% YoY and by 13% QoQ
The debt has soared by 51% year-on-year and by 6% since the previous quarter
Sector: Healthcare
Industry: Biotechnology
Website: http://www.heatbio.com/
Peers: OPTN OPK ORGO

Key stats

What are the main financial stats of SCPX
Market
Shares outstanding
36.03M
Market cap
$6.49M
Enterprise value
$20.09M
Valuations
Price to earnings (P/E)
N/A
Price to book (P/B)
0.15
Price to sales (P/S)
0.67
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
2.87
Earnings
Revenue
$6.99M
EBIT
-$45.01M
EBITDA
-$36.93M
Free cash flow
-$33.3M
Per share
EPS
-$1.74
Free cash flow per share
-$1.28
Book value per share
$1.2
Revenue per share
$0.27
TBVPS
$1.96
Balance sheet
Total assets
$51.04M
Total liabilities
$22.74M
Debt
$14.04M
Equity
$31.4M
Working capital
-$5.34M
Liquidity
Debt to equity
0.45
Current ratio
0.47
Quick ratio
0.3
Net debt/EBITDA
-0.37
Margins
EBITDA margin
-528%
Gross margin
60.9%
Net margin
-646.4%
Operating margin
-600.9%
Efficiency
Return on assets
-61.8%
Return on equity
-101.4%
Return on invested capital
-77.4%
Return on capital employed
-110%
Return on sales
-643.5%
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

SCPX stock price

How has the Scorpius Holdings stock price performed over time
Intraday
0%
1 week
12.5%
1 month
10.16%
1 year
-74.88%
YTD
-59.12%
QTD
11.11%

Financial performance

How have Scorpius Holdings's revenue and profit performed over time
Revenue
$6.99M
Gross profit
$4.26M
Operating income
-$42.03M
Net income
-$45.22M
Gross margin
60.9%
Net margin
-646.4%
The gross margin has soared by 124% from the previous quarter but it has contracted by 22% YoY
The company's operating margin has surged by 95% YoY and by 74% QoQ
The net margin has soared by 94% year-on-year and by 74% since the previous quarter
The operating income has increased by 19% since the previous quarter and by 3.5% year-on-year

Growth

What is Scorpius Holdings's growth rate over time

Valuation

What is Scorpius Holdings stock price valuation
P/E
N/A
P/B
0.15
P/S
0.67
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
2.87
The EPS has grown by 18% from the previous quarter but it has contracted by 2.4% YoY
The P/B is 83% below the 5-year quarterly average of 0.9 and 63% below the last 4 quarters average of 0.4
Scorpius Holdings's equity has shrunk by 58% YoY and by 13% QoQ
SCPX's price to sales (P/S) is 98% less than its 5-year quarterly average of 31.5 and 94% less than its last 4 quarters average of 10.7

Efficiency

How efficient is Scorpius Holdings business performance
The company's return on equity has shrunk by 111% YoY
The ROS has soared by 95% YoY and by 73% from the previous quarter
The ROA has plunged by 67% YoY but it has grown by 2.8% from the previous quarter
SCPX's return on invested capital has dropped by 63% year-on-year

Dividends

What is SCPX's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for SCPX.

Financial health

How did Scorpius Holdings financials performed over time
Scorpius Holdings's total assets is 124% more than its total liabilities
The quick ratio has plunged by 87% YoY but it has grown by 7% from the previous quarter
The current ratio has dropped by 83% year-on-year and by 53% since the previous quarter
The debt is 55% smaller than the equity
Scorpius Holdings's equity has shrunk by 58% YoY and by 13% QoQ
The debt has soared by 51% year-on-year and by 6% since the previous quarter

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.